✦ LIBER ✦

Intermittent androgen suppression with buserelin and nilutamide for the treatment of prostate cancer patients

✍ Scribed by E.M.C. Schasfoort; P. Heathcote; M.T.W.T. Lock; M. Zerbib; H.E. Dijkema; H. Vergunst; M. Srougi; D.W.W. Newling

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of biochemical progre

✍ Alexandre de la Taille; Marc Zerbib; Sophie Conquy; Delphine Amsellem-Ouazana; N 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Current status of androgen suppression a

✍ Mack Roach III 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Total androgen blockade with the use of

✍ R. A. Janknegt; Anandron International Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB 👁 1 views

Measurements of tissue polypeptide-speci

✍ Theyer, G; Holub, S; Dürer, A; Andert, S; Haberl, I; Theyer, U; Hamilton, G 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 751 KB

The change in free-to-total prostate-spe

✍ Akakura, K 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Adverse effects to quality of life arisi

✍ N.A. Spry; L. Kristjanson; B. Hooton; L. Hayden; G. Neerhut; H. Gurney; T. Coric 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 287 KB